Search clinical trials for: Insulin glargine,300 U/mL
Total 1023 results
-
University of JordanCompletedDiabetes Mellitus, Type 2Jordan
-
University of CopenhagenCompleted
-
University of BasrahRecruiting
-
Postgraduate Institute of Medical Education and...All India Institute of Medical Sciences, Bhubaneswar; Jawaharlal Institute... and other collaboratorsRecruiting
-
Weill Cornell Medical College in QatarNovo Nordisk A/STerminated
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, Spain, United States, India, Brazil
-
Heidelberg UniversityUnknown
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Terminated
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, China, India, Iran, Islamic Republic of, Korea, Republic of, Russian Federation, Poland, Japan, Italy, Canada, Greece
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, India, Italy, Argentina, France, Germany, Mexico, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Israel, Italy, Russian Federation, Turkey, Japan, Czechia, Spain, United Kingdom, United States, Australia, Hungary, Puerto Rico, Mexico, Austria, Germany, Denmark, Croatia, Greece, Romania, Taiwan, Brazil, Netherlands, Poland, Lithuania and more
-
São Paulo State UniversityCompletedIntestinal DiseasesBrazil
-
Hospital Universitari de BellvitgeRecruitingPostoperative Complications | Sarcopenia | Infection;Post Surg ProcedureSpain
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Russian Federation, United Kingdom, South Africa
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
SanofiTerminatedDiabetes Mellitus, Type 2Australia
-
Yale UniversityCompletedType 1 Diabetes MellitusUnited States
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
University of WashingtonCompletedType 1 DiabetesUnited States
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Germany, Puerto Rico, United Kingdom, Spain, Canada, Brazil, Korea, Republic of, India, Israel, Russian Federation, South Africa
-
Karolinska InstitutetUnknownDiabetes Mellitus Type 1Sweden
-
University of New MexicoCompletedDiabetes MellitusUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
Mannkind CorporationTerminated
-
Eli Lilly and CompanyCipla Ltd.RecruitingDiabetes Mellitus, Type 2India
-
Johns Hopkins UniversityNational Institutes of Health (NIH); MedtronicCompleted
-
Xijing HospitalUnknown
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
WockhardtWithdrawn
-
Emory UniversityCompletedCoronary Artery DiseaseUnited States
-
Zentrums für Rhinologie und Allergologie WiesbadenUniversity Hospital of CologneCompletedAllergic Rhinitis
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonCompleted
-
Emory UniversityNovo Nordisk A/SCompletedType 2 DiabetesUnited States
-
King Edward Medical UniversityCompletedTo Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in ChildrenPakistan
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
SanofiCompletedDiabetes MellitusUnited States
-
Cairo UniversityCompletedDiabetes Mellitus (DM)Egypt
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes | T2DUnited States, Mexico, Argentina, Puerto Rico
-
Eli Lilly and CompanyCompleted
-
Massachusetts General HospitalSanofiCompletedType 1 Diabetes | Dawn PhenomenonUnited States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusChina, Argentina, Mexico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Argentina
-
Tamra DukatzSanofiCompleted
-
Mountain Diabetes and Endocrine CenterCompletedInsulin Resistance | Type 2 DiabetesUnited States